Evaluation of the serum levels of galectin-3 in patients with oral lichen planus disease

被引:4
作者
Ghapanchi, Janan [1 ]
Andisheh-Tadbir, Azadeh [2 ]
Torkaman, Pooriya [1 ]
Malekzadeh, Mahyar [3 ]
Mardani, Maryam [2 ]
机构
[1] Shiraz Univ Med Sci, Sch Dent, Dept Oral & Maxillofacial Med, Shiraz, Iran
[2] Shiraz Univ Med Sci, Oral & Dent Dis Res Ctr, Sch Dent, Shiraz, Iran
[3] Shiraz Univ Med Sci, Sch Med, Shiraz Inst Canc Res, Shiraz, Iran
关键词
biomarker; ELISA; galectin-3; inflammatory disease; oral lichen planus; SQUAMOUS-CELL CARCINOMA; EXPRESSION; DIAGNOSIS; CANCER; METASTASIS;
D O I
10.1111/odi.13012
中图分类号
R78 [口腔科学];
学科分类号
1003 ;
摘要
Objectives Galectin-3, a member of beta-galactoside-binding proteins, can be found in cytoplasm and nucleus as well as extracellularly in various tissues and involved in many physiological and pathological processes. We aimed to measure the serum levels of galectin-3 in oral lichen planus (OLP) disease and compare the result with that observed in healthy ones. Materials and Methods In this cross-sectional study, the serum levels of galectin-3 were measured in 56 healthy individuals and 53 pathologically proven OLP patients including those with atrophic/erosive (33 cases) or reticular (20 cases) lesions, using enzyme-linked immunosorbent assay (ELISA). Results Compared with healthy individuals (1.1 +/- 0.4 ng/ml), galectin-3 serum levels in patients with OLP (3.1 +/- 1.1 ng/ml) were significantly elevated (p < 0.0001). Serum galectin-3 levels were elevated significantly in patients with atrophic/erosive lesions compared to those of reticular (3.9 +/- 2.1 ng/ml vs. 1.9 +/- 1.4 ng/ml, p = 0.001), but it has not associated with age and gender. Conclusions The elevation of galectin-3 in OLP is a future tool to increase the knowledge about the possible etiology of the disease and may be helpful to differentiate atrophic/erosive lesions from reticular ones. To the best of our knowledge, this is the first study evaluated the serum galectin-3 levels in OLP.
引用
收藏
页码:466 / 470
页数:5
相关论文
共 42 条
[1]   Sensitivity and Specificity of Galectin-3 and Glypican-3 in Follicular-Patterned and Other Thyroid Neoplasms [J].
Al-Sharaky, Dalia Rifaat ;
Younes, Sheren Fouad .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2016, 10 (03) :EC6-EC10
[2]  
Andisheh-Tadbir Azadeh, 2018, Asian Pac J Cancer Prev, V19, P689
[3]   Comparative analysis of galectins in primary tumors and tumor metastasis in human pancreatic cancer [J].
Berberat, PO ;
Friess, H ;
Wang, L ;
Zhu, ZW ;
Bley, T ;
Frigeri, L ;
Zimmermann, A ;
Büchler, MW .
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY, 2001, 49 (04) :539-549
[4]  
Chen HY, 2005, ARCH IMMUNOL THER EX, V53, P497
[5]   Diagnostic Utility of Galectin-3 in Thyroid Cancer [J].
Chiu, Connie G. ;
Strugnell, Scott S. ;
Griffith, Obi L. ;
Jones, Steven J. M. ;
Gown, Allen M. ;
Walker, Blair ;
Nabi, Ivan R. ;
Wiseman, Sam M. .
AMERICAN JOURNAL OF PATHOLOGY, 2010, 176 (05) :2067-2081
[6]   VEGFR1 and VEGFR2 Involvement in Extracellular Galectin-1-and Galectin-3-Induced Angiogenesis [J].
D'Haene, Nicky ;
Sauvage, Sebastien ;
Maris, Calliope ;
Adanja, Ivan ;
Le Mercier, Marie ;
Decaestecker, Christine ;
Baum, Linda ;
Salmon, Isabelle .
PLOS ONE, 2013, 8 (06)
[7]  
Dancer JY, 2010, ARCH PATHOL LAB MED, V134, P90, DOI 10.1043/2008-0392-OAR1.1
[8]   Galectin-3 in autoimmunity and autoimmune diseases [J].
de Oliveira, Felipe L. ;
Gatto, Mariele ;
Bassi, Nicola ;
Luisetto, Roberto ;
Ghirardello, Anna ;
Punzi, Leonardo ;
Doria, Andrea .
EXPERIMENTAL BIOLOGY AND MEDICINE, 2015, 240 (08) :1019-1028
[9]   The Role of Galectins in Protein Trafficking [J].
Delacour, Delphine ;
Koch, Annett ;
Jacob, Ralf .
TRAFFIC, 2009, 10 (10) :1405-1413
[10]   Galectin-3 as a novel biomarker for disease diagnosis and a target for therapy [J].
Dong, Rui ;
Zhang, Min ;
Hu, Qunying ;
Zheng, Shan ;
Soh, Andrew ;
Zheng, Yijie ;
Yuan, Hui .
INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2018, 41 (02) :599-614